BioCentury | Jul 14, 2020
Deals

July 13 Quick Takes: Spudich, Rutter to lead start-up Kainomyx; plus deals for Ovid-Angelini, Dewpoint-Merck and Kiadis-Sanofi

...and Annamma Spudich, the company raised $7.5 million from Chiron Corp. co-founder and Kainomyx Chairman William Rutter...
BioCentury | Apr 11, 2005
Company News

Cytokinetics board of directors update

...Francisco, Calif. Business: Cancer, Cardiovascular Appointed: Mark McDade, CEO of Protein Design Labs Inc. Resigned: William Rutter WIR...
BioCentury | Mar 14, 2005
Company News

Sangamo board of directors update

...Calif. Business: Cardiovascular, Cancer, Neurology Appointed: Margaret Liu, visiting professor at the Karolinska Institutet Departing: William Rutter WIR...
BioCentury | Sep 22, 2003
Finance

Ebb & Flow

...of the company. "There's only been three chairmen in our history," he noted. CHIR co-founder William Rutter...
BioCentury | Aug 25, 2003
Company News

NuGen board of directors update

...NuGen Technologies Inc. , San Carlos, Calif. Business: Microarrays Appointed: William Rutter, co-founder and former chairman of...
BioCentury | Dec 18, 2000
Emerging Company Profile

Prospect Genomics Inc.

...Baker, Stephen Burley, Andrej Sali, Ken Dill, Peter Kollman, Irwin Kuntz, Richard Goold, Tod Klingler, William Rutter...
BioCentury | Jan 17, 2000
Company News

Sangamo board of directors update

...Sangamo BioSciences Inc., Point Richmond, Calif. Business: Drug discovery, Cancer, Infectious diseases Appointed: William Rutter, former Chairman...
BioCentury | Sep 13, 1999
Company News

Cytokinetics board of directors update

...Financing, B11) Cytokinetics Inc., South San Francisco, Calif. Business: Drug discovery Appointed: William Rutter, chairman emeritus of...
BioCentury | May 17, 1999
Company News

Chiron board of directors update

...Corp. (CHIR), Emeryville, Calif. Business: Biopharmaceuticals Appointed: Sean Lance, president and CEO, as chairman, succeeding William Rutter...
BioCentury | Oct 12, 1998
Finance

Best of Biotech Awards for 1998

...of EPO and the discovery and development of Neupogen G-CSF Special Recognition for an Individual William Rutter...
Items per page:
1 - 10 of 12
BioCentury | Jul 14, 2020
Deals

July 13 Quick Takes: Spudich, Rutter to lead start-up Kainomyx; plus deals for Ovid-Angelini, Dewpoint-Merck and Kiadis-Sanofi

...and Annamma Spudich, the company raised $7.5 million from Chiron Corp. co-founder and Kainomyx Chairman William Rutter...
BioCentury | Apr 11, 2005
Company News

Cytokinetics board of directors update

...Francisco, Calif. Business: Cancer, Cardiovascular Appointed: Mark McDade, CEO of Protein Design Labs Inc. Resigned: William Rutter WIR...
BioCentury | Mar 14, 2005
Company News

Sangamo board of directors update

...Calif. Business: Cardiovascular, Cancer, Neurology Appointed: Margaret Liu, visiting professor at the Karolinska Institutet Departing: William Rutter WIR...
BioCentury | Sep 22, 2003
Finance

Ebb & Flow

...of the company. "There's only been three chairmen in our history," he noted. CHIR co-founder William Rutter...
BioCentury | Aug 25, 2003
Company News

NuGen board of directors update

...NuGen Technologies Inc. , San Carlos, Calif. Business: Microarrays Appointed: William Rutter, co-founder and former chairman of...
BioCentury | Dec 18, 2000
Emerging Company Profile

Prospect Genomics Inc.

...Baker, Stephen Burley, Andrej Sali, Ken Dill, Peter Kollman, Irwin Kuntz, Richard Goold, Tod Klingler, William Rutter...
BioCentury | Jan 17, 2000
Company News

Sangamo board of directors update

...Sangamo BioSciences Inc., Point Richmond, Calif. Business: Drug discovery, Cancer, Infectious diseases Appointed: William Rutter, former Chairman...
BioCentury | Sep 13, 1999
Company News

Cytokinetics board of directors update

...Financing, B11) Cytokinetics Inc., South San Francisco, Calif. Business: Drug discovery Appointed: William Rutter, chairman emeritus of...
BioCentury | May 17, 1999
Company News

Chiron board of directors update

...Corp. (CHIR), Emeryville, Calif. Business: Biopharmaceuticals Appointed: Sean Lance, president and CEO, as chairman, succeeding William Rutter...
BioCentury | Oct 12, 1998
Finance

Best of Biotech Awards for 1998

...of EPO and the discovery and development of Neupogen G-CSF Special Recognition for an Individual William Rutter...
Items per page:
1 - 10 of 12